Chong Kun Dang Holdings Corp. (KRX:001630)

South Korea · Delayed Price · Currency is KRW

53,200

-500 (-0.93%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Medicine	925.73B	846.81B	897.37B	928.41B	851.48B
Medicine Growth	9.32%	-5.63%	-3.34%	9.03%	-
Consolidation Adjustment	-40.60B	-31.58B	-50.47B	-68.33B	-42.22B
Other	72.62B	64.55B	62.07B	65.89B	48.85B
Other Growth	12.50%	3.99%	-5.80%	34.88%	-
Total	957.75B	879.78B	908.96B	925.98B	858.12B
Total Growth	8.86%	-3.21%	-1.84%	7.91%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	828.21B	724.60B	803.42B	824.01B	709.09B
South Korea Growth	14.30%	-9.81%	-2.50%	16.21%	-
Asia	63.41B	76.15B	89.27B	89.27B	109.28B
Asia Growth	-16.74%	-14.69%	0%	-18.32%	-
Europe	48.70B	56.28B	27.79B	27.79B	21.21B
Europe Growth	-13.46%	102.51%	0%	31.05%	-
Middle East	11.17B	12.90B	2.49B	2.49B	13.35B
Middle East Growth	-13.44%	417.98%	0%	-81.34%	-
Other	38.71B	34.47B	26.58B	26.58B	47.40B
Other Growth	12.30%	29.67%	0%	-43.92%	-
Consolidation Adjustment	-32.63B	-24.74B	-40.71B	-51.45B	-42.22B
Total	957.57B	879.66B	908.84B	918.68B	858.12B
Total Growth	8.86%	-3.21%	-1.07%	7.06%	-

Source: S&P Global Market Intelligence.